Apollo Hospitals announced impressive third-quarter earnings. Net profit surged 35% year-on-year to Rs 502 crore. Revenue grew 17% to Rs 6,477 crore. All business segments showed strong growth. The company continues to invest in advanced clinical capabilities. Citi maintains a Buy rating with a target price of Rs 9,600.
Recent Posts
- Honda Motor Co., Ltd. (HMC:NYSE) announced its consolidated financial results for the fiscal third quarter ended December 31, 2025.
- Tokenized commodities market crosses $6B amid gold’s historic rally
- Britannia Industries share price jumps nearly 5% after Q3 results. Buy or sell?
- Royal Enfield bikes maker Eicher Motors share price rallies 7% after strong Q3 results. Should you buy the stock?
- Jhunjhunwala stock Titan share price jumps over 2.5% on strong Q3 results – Buy, sell or hold?